vs
安富利（AVT）与丹纳赫（DHR）财务数据对比。点击上方公司名可切换其他公司
安富利的季度营收约是丹纳赫的1.1倍（$6.3B vs $6.0B），丹纳赫净利率更高（17.3% vs 1.0%，领先16.3%），安富利同比增速更快（11.6% vs 3.7%），丹纳赫自由现金流更多（$1.1B vs $192.9M），过去两年安富利的营收复合增速更高（5.7% vs 1.8%）
安富利是全球知名的电子元器件分销商，总部位于美国亚利桑那州凤凰城，由查尔斯·安富利于1921年创立，最初起步于曼哈顿无线电街。1955年公司正式注册成立，1961年在纽约证券交易所上市，2018年5月8日转至纳斯达克挂牌交易，股票代码仍为AVT。
丹纳赫是总部位于美国华盛顿特区的医疗健康企业，聚焦生物技术、生命科学与诊断领域的产品研发。公司下设三大业务板块：生物技术板块开发治疗相关产品，生命科学板块覆盖疾病溯源、新疗法研发、药物疫苗与基因编辑技术的测试生产，诊断板块研发检测仪器，为全球生命健康产业提供核心支持。
AVT vs DHR — 直观对比
营收规模更大
AVT
是对方的1.1倍
$6.0B
营收增速更快
AVT
高出7.9%
3.7%
净利率更高
DHR
高出16.3%
1.0%
自由现金流更多
DHR
多$892.1M
$192.9M
两年增速更快
AVT
近两年复合增速
1.8%
损益表 — Q2 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $6.3B | $6.0B |
| 净利润 | $61.7M | $1.0B |
| 毛利率 | 10.5% | 60.3% |
| 营业利润率 | 2.3% | 22.6% |
| 净利率 | 1.0% | 17.3% |
| 营收同比 | 11.6% | 3.7% |
| 净利润同比 | -29.2% | 7.9% |
| 每股收益（稀释后） | $0.75 | $1.45 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AVTDHR
| Q1 26 | — | $6.0B | ||
| Q4 25 | $6.3B | $6.8B | ||
| Q3 25 | $5.9B | $6.1B | ||
| Q2 25 | $5.6B | $5.9B | ||
| Q1 25 | $5.3B | $5.7B | ||
| Q4 24 | $5.7B | $6.5B | ||
| Q3 24 | $5.6B | $5.8B | ||
| Q2 24 | $5.6B | $5.7B |
净利润AVTDHR
| Q1 26 | — | $1.0B | ||
| Q4 25 | $61.7M | $1.2B | ||
| Q3 25 | $51.7M | $908.0M | ||
| Q2 25 | $6.1M | $555.0M | ||
| Q1 25 | $87.9M | $954.0M | ||
| Q4 24 | $87.3M | $1.1B | ||
| Q3 24 | $59.0M | $818.0M | ||
| Q2 24 | $82.7M | $907.0M |
毛利率AVTDHR
| Q1 26 | — | 60.3% | ||
| Q4 25 | 10.5% | 58.0% | ||
| Q3 25 | 10.4% | 58.2% | ||
| Q2 25 | 10.6% | 59.3% | ||
| Q1 25 | 11.1% | 61.2% | ||
| Q4 24 | 10.5% | 59.5% | ||
| Q3 24 | 10.8% | 58.7% | ||
| Q2 24 | 11.6% | 59.7% |
营业利润率AVTDHR
| Q1 26 | — | 22.6% | ||
| Q4 25 | 2.3% | 22.0% | ||
| Q3 25 | 2.4% | 19.1% | ||
| Q2 25 | 1.3% | 12.8% | ||
| Q1 25 | 2.7% | 22.2% | ||
| Q4 24 | 2.7% | 21.8% | ||
| Q3 24 | 2.5% | 16.5% | ||
| Q2 24 | 3.0% | 20.3% |
净利率AVTDHR
| Q1 26 | — | 17.3% | ||
| Q4 25 | 1.0% | 17.5% | ||
| Q3 25 | 0.9% | 15.0% | ||
| Q2 25 | 0.1% | 9.3% | ||
| Q1 25 | 1.7% | 16.6% | ||
| Q4 24 | 1.5% | 16.6% | ||
| Q3 24 | 1.1% | 14.1% | ||
| Q2 24 | 1.5% | 15.8% |
每股收益（稀释后）AVTDHR
| Q1 26 | — | $1.45 | ||
| Q4 25 | $0.75 | $1.69 | ||
| Q3 25 | $0.61 | $1.27 | ||
| Q2 25 | $0.09 | $0.77 | ||
| Q1 25 | $1.01 | $1.32 | ||
| Q4 24 | $0.99 | $1.50 | ||
| Q3 24 | $0.66 | $1.12 | ||
| Q2 24 | $0.93 | $1.22 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $286.5M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $4.9B | — |
| 总资产 | $13.2B | — |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AVTDHR
| Q1 26 | — | — | ||
| Q4 25 | $286.5M | — | ||
| Q3 25 | $175.5M | — | ||
| Q2 25 | $192.4M | — | ||
| Q1 25 | $188.9M | — | ||
| Q4 24 | $172.1M | — | ||
| Q3 24 | $267.5M | — | ||
| Q2 24 | $310.9M | — |
总债务AVTDHR
| Q1 26 | — | — | ||
| Q4 25 | — | $18.4B | ||
| Q3 25 | — | $16.9B | ||
| Q2 25 | — | $17.4B | ||
| Q1 25 | — | $16.5B | ||
| Q4 24 | — | $16.0B | ||
| Q3 24 | — | $17.5B | ||
| Q2 24 | — | $17.0B |
股东权益AVTDHR
| Q1 26 | — | — | ||
| Q4 25 | $4.9B | $52.5B | ||
| Q3 25 | $4.8B | $51.1B | ||
| Q2 25 | $5.0B | $52.3B | ||
| Q1 25 | $4.9B | $50.8B | ||
| Q4 24 | $4.8B | $49.5B | ||
| Q3 24 | $5.0B | $51.3B | ||
| Q2 24 | $4.9B | $49.9B |
总资产AVTDHR
| Q1 26 | — | — | ||
| Q4 25 | $13.2B | $83.5B | ||
| Q3 25 | $12.4B | $79.9B | ||
| Q2 25 | $12.1B | $81.6B | ||
| Q1 25 | $11.7B | $79.1B | ||
| Q4 24 | $11.9B | $77.5B | ||
| Q3 24 | $12.6B | $80.6B | ||
| Q2 24 | $12.2B | $78.6B |
负债/权益比AVTDHR
| Q1 26 | — | — | ||
| Q4 25 | — | 0.35× | ||
| Q3 25 | — | 0.33× | ||
| Q2 25 | — | 0.33× | ||
| Q1 25 | — | 0.32× | ||
| Q4 24 | — | 0.32× | ||
| Q3 24 | — | 0.34× | ||
| Q2 24 | — | 0.34× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $208.2M | $1.3B |
| 自由现金流经营现金流 - 资本支出 | $192.9M | $1.1B |
| 自由现金流率自由现金流/营收 | 3.1% | 18.2% |
| 资本支出强度资本支出/营收 | 0.2% | 4.0% |
| 现金转化率经营现金流/净利润 | 3.37× | 1.28× |
| 过去12个月自由现金流最近4个季度 | $217.7M | $5.3B |
8季度趋势，按日历期对齐
经营现金流AVTDHR
| Q1 26 | — | $1.3B | ||
| Q4 25 | $208.2M | $2.1B | ||
| Q3 25 | $-144.6M | $1.7B | ||
| Q2 25 | $139.5M | $1.3B | ||
| Q1 25 | $140.9M | $1.3B | ||
| Q4 24 | $337.8M | $2.0B | ||
| Q3 24 | $106.3M | $1.5B | ||
| Q2 24 | $274.3M | $1.4B |
自由现金流AVTDHR
| Q1 26 | — | $1.1B | ||
| Q4 25 | $192.9M | $1.7B | ||
| Q3 25 | $-169.2M | $1.4B | ||
| Q2 25 | $79.9M | $1.1B | ||
| Q1 25 | $114.1M | $1.1B | ||
| Q4 24 | $308.5M | $1.5B | ||
| Q3 24 | $74.5M | $1.2B | ||
| Q2 24 | $248.0M | $1.1B |
自由现金流率AVTDHR
| Q1 26 | — | 18.2% | ||
| Q4 25 | 3.1% | 25.5% | ||
| Q3 25 | -2.9% | 22.6% | ||
| Q2 25 | 1.4% | 18.4% | ||
| Q1 25 | 2.1% | 18.4% | ||
| Q4 24 | 5.4% | 23.0% | ||
| Q3 24 | 1.3% | 21.0% | ||
| Q2 24 | 4.5% | 19.7% |
资本支出强度AVTDHR
| Q1 26 | — | 4.0% | ||
| Q4 25 | 0.2% | 5.4% | ||
| Q3 25 | 0.4% | 4.8% | ||
| Q2 25 | 1.1% | 4.2% | ||
| Q1 25 | 0.5% | 4.3% | ||
| Q4 24 | 0.5% | 7.9% | ||
| Q3 24 | 0.6% | 5.1% | ||
| Q2 24 | 0.5% | 5.0% |
现金转化率AVTDHR
| Q1 26 | — | 1.28× | ||
| Q4 25 | 3.37× | 1.77× | ||
| Q3 25 | -2.79× | 1.83× | ||
| Q2 25 | 22.91× | 2.41× | ||
| Q1 25 | 1.60× | 1.36× | ||
| Q4 24 | 3.87× | 1.86× | ||
| Q3 24 | 1.80× | 1.85× | ||
| Q2 24 | 3.32× | 1.56× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AVT
| Electronic Components | $5.9B | 93% |
| Premier Farnell | $427.1M | 7% |
DHR
暂无分部数据
